This Crypto Is Set to Explode in December

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Richard Pops Biography and Net Worth

Chairman & CEO of Alkermes

Richard Pops serves as Alkermes’ Chairman and Chief Executive Officer. He joined Alkermes as CEO in 1991 and under his leadership, the organization has grown from a privately held company with 25 employees to an international, publicly-traded biopharmaceutical company with more than 2,000 employees.

Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA).

What is Richard F. Pops' net worth?: The estimated net worth of Richard F. Pops is at least $876,801.52 as of March 8th, 2024. Mr. Pops owns 29,512 shares of Alkermes stock worth more than $876,802 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Pops may own. Additionally, Mr. Pops receives a salary of $2,610,000.00 as Chairman & CEO at Alkermes. Learn More about Richard F. Pops' net worth.
How old is Richard F. Pops?: Mr. Pops is currently 62 years old. There are 6 older executives and no younger executives at Alkermes. Learn More on Richard F. Pops' age.
What is Richard F. Pops' salary?: As the Chairman & CEO of Alkermes plc, Mr. Pops earns $2,610,000.00 per year. Learn More on Richard F. Pops' salary.
How do I contact Richard F. Pops?: The corporate mailing address for Mr. Pops and other Alkermes executives is 1 BURLINGTON ROAD CONNAUGHT HOUSE, DUBLIN L2, DUBLIN 4. Alkermes can also be reached via phone at (531) 772-8000 and via email at [email protected]. Learn More on Richard F. Pops' contact information.
Has Richard F. Pops been buying or selling shares of Alkermes?: Richard F. Pops has not been actively trading shares of Alkermes during the last quarter. Most recently, Richard F. Pops sold 93,747 shares of the business's stock in a transaction on Friday, May 6th. The shares were sold at an average price of $27.85, for a transaction totalling $2,610,853.95. Following the completion of the sale, the chief executive officer now directly owns 968,299 shares of the company's stock, valued at $26,967,127.15. Learn More on Richard F. Pops' trading history.
Who are Alkermes' active insiders?: Alkermes' insider roster includes Emily Alva (Director), David Anstice (Director), Iain Brown (CFO), Shane Cooke (Director), Wendy Dixon (Director), David Gaffin (SVP), Craig Hopkinson (EVP), Blair Jackson (COO), Michael Landine (SVP), Cato Laurencin (Director), Christian Nichols (SVP), Richard Pops (Chairman & CEO), and Nancy Wysenski (Director). Learn More on Alkermes' active insiders.
Are insiders buying or selling shares of Alkermes?: During the last year, insiders at the sold shares 7 times. They sold a total of 158,155 shares worth more than $4,865,621.63. The most recent insider tranaction occured on December, 9th when EVP Craig C Hopkinson sold 61,151 shares worth more than $1,961,112.57. Insiders at Alkermes own 4.9% of the company. Learn More about insider trades at Alkermes.
Information on this page was last updated on 12/9/2024.

Richard F. Pops Insider Trading History at Alkermes

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/6/2022	Sell	93,747	$27.85	$2,610,853.95	968,299
5/18/2021	Sell	150,000	$21.90	$3,285,000.00
5/11/2021	Sell	150,000	$22.09	$3,313,500.00	942,040
5/6/2021	Sell	100,000	$21.79	$2,179,000.00	892,040
5/14/2020	Sell	75,000	$15.00	$1,125,000.00	834,094
5/7/2020	Sell	50,000	$14.63	$731,500.00	809,094
4/2/2020	Sell	50,000	$13.79	$689,500.00	809,094
3/26/2020	Sell	75,000	$14.36	$1,077,000.00	834,094
11/14/2019	Sell	100,000	$19.50	$1,950,000.00	816,433
11/7/2019	Sell	69,795	$19.81	$1,382,638.95	786,228
9/19/2019	Sell	100,000	$21.54	$2,154,000.00	816,433
9/12/2019	Sell	100,000	$22.68	$2,268,000.00	816,433
9/5/2019	Sell	100,000	$20.18	$2,018,000.00	816,433
5/23/2019	Sell	110,000	$24.88	$2,736,800.00	776,433
5/16/2019	Sell	60,000	$25.42	$1,525,200.00	776,433
3/13/2019	Sell	60,000	$33.32	$1,999,200.00	760,604
3/5/2019	Sell	50,000	$33.63	$1,681,500.00	766,433
5/22/2018	Sell	20,000	$45.46	$909,200.00	686,352
5/15/2018	Sell	50,000	$46.38	$2,319,000.00	716,352
5/8/2018	Sell	50,000	$44.32	$2,216,000.00	716,352
5/1/2018	Sell	50,000	$44.02	$2,201,000.00	716,352
11/2/2017	Sell	50,000	$48.87	$2,443,500.00
5/24/2017	Sell	25,000	$57.42	$1,435,500.00	649,137
5/17/2017	Sell	50,000	$58.19	$2,909,500.00	680,406
5/10/2017	Sell	25,000	$57.29	$1,432,250.00	655,406
11/29/2016	Sell	30,000	$56.98	$1,709,400.00	638,962
11/22/2016	Sell	30,000	$58.66	$1,759,800.00	638,962
4/19/2016	Sell	18,750	$40.15	$752,812.50	595,247
4/12/2016	Sell	25,000	$37.79	$944,750.00	601,497
3/22/2016	Sell	25,000	$31.77	$794,250.00	601,497
3/15/2016	Sell	25,000	$31.40	$785,000.00	581,307
12/7/2015	Sell	37,500	$72.06	$2,702,250.00	553,497
12/1/2015	Sell	50,000	$72.29	$3,614,500.00	553,497
9/17/2015	Sell	50,000	$71.27	$3,563,500.00	542,917
9/10/2015	Sell	50,000	$67.57	$3,378,500.00	542,917
12/11/2014	Sell	100,000	$56.04	$5,604,000.00
11/13/2014	Sell	100,000	$52.87	$5,287,000.00
9/17/2014	Sell	50,000	$44.89	$2,244,500.00
7/2/2014	Sell	50,000	$51.69	$2,584,500.00
6/25/2014	Sell	50,000	$49.87	$2,493,500.00
6/18/2014	Sell	50,000	$46.72	$2,336,000.00

Richard F. Pops Buying and Selling Activity at Alkermes

Alkermes Company Overview

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Today's Range

Now: $29.71

$29.53

$30.37

50 Day Range

MA: $28.81

$25.70

$31.46

2 Week Range

Now: $29.71

$22.90

$32.88

Volume

4,636,200 shs

Average Volume

1,822,512 shs

Market Capitalization

$4.81 billion

P/E Ratio

15.24

Dividend Yield

N/A

Beta

0.49

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Richard Pops Biography and Net Worth

What is Richard F. Pops' net worth?

How old is Richard F. Pops?

What is Richard F. Pops' salary?

How do I contact Richard F. Pops?

Has Richard F. Pops been buying or selling shares of Alkermes?

Who are Alkermes' active insiders?

Are insiders buying or selling shares of Alkermes?